136 related articles for article (PubMed ID: 2389463)
1. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
[No Abstract] [Full Text] [Related]
2. Usefulness of serum interleukin 2 receptor levels in renal allograft recipients.
Plaza JJ; Blum G; Ortiz A; Hernando L; Feijoo E; Sanz J; Garcia R; Egido J; Ortiz F
Transplant Proc; 1992 Feb; 24(1):63-4. PubMed ID: 1539346
[No Abstract] [Full Text] [Related]
3. Soluble CD23 and interleukin-2 receptor levels in renal allograft recipients.
Beksaç M; Dalva K; Gönenç F; Dalva I; Gariboğlu S; Batur N; Cetin S
Transplant Proc; 1993 Apr; 25(2):2145-7. PubMed ID: 8470296
[No Abstract] [Full Text] [Related]
4. Determination of soluble IL-2 receptors in kidney graft recipients--a 6-month follow-up.
Manfro RC; Pohanka E; Tomlanovich SJ; Benet LZ; Salvatierra O; Garovoy MR
Transplant Proc; 1990 Aug; 22(4):1861-2. PubMed ID: 2389461
[No Abstract] [Full Text] [Related]
5. Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.
Perkins JD; Nelson DL; Rakela J; Grambsch PM; Krom RA
Transplant Proc; 1989 Feb; 21(1 Pt 2):2275-6. PubMed ID: 2540568
[No Abstract] [Full Text] [Related]
6. The assay of soluble IL-2R receptor levels in graft microenvironment can be helpful in differential diagnosis of transplant dysfunction.
Yussim A; Shapira Z; Shohat B; Shmueli D; Zingerman B; Livne E; Klein T
Transplant Proc; 1991 Feb; 23(1 Pt 1):260-2. PubMed ID: 1990528
[No Abstract] [Full Text] [Related]
7. Activation markers in late rejection of kidney allografts: fine needle aspiration biopsy analysis.
Gonzalez-Posada JM; Garcia Castro C; Torres A; Lorenzo V; Losada M; Hernandez D; Maceira B; Salido E
Transplant Proc; 1992 Feb; 24(1):65-6. PubMed ID: 1539347
[No Abstract] [Full Text] [Related]
8. Evaluation of serum immunological parameters in acute renal allograft rejection.
Yang J; Li XW; Zheng FL; Bi ZQ
Transplant Proc; 1996 Jun; 28(3):1443-4. PubMed ID: 8658732
[No Abstract] [Full Text] [Related]
9. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve.
Yilmaz S; Kallio E; Yilmaz A; Häyry P
Transplant Proc; 1995 Feb; 27(1):927. PubMed ID: 7879233
[No Abstract] [Full Text] [Related]
10. Serial monitoring shows plasma protein C and free protein S levels are decreased during human acute renal allograft rejection.
Tsuchida A; Thomson NM; Salem HH; Atkins RC; Hancock WW
Transplant Proc; 1990 Oct; 22(5):2134-6. PubMed ID: 2145671
[No Abstract] [Full Text] [Related]
11. Immune monitoring: does the reality fulfill the promise?
Tice DG; Heintz S; Scruggs B; Hubbell C; Szmalc FS
Transplant Proc; 1993 Aug; 25(4):2654. PubMed ID: 8356709
[No Abstract] [Full Text] [Related]
12. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
Noronha IL; Daniel V; Rambausek M; Waldherr R; Opelz G
Transplant Proc; 1990 Aug; 22(4):1859-60. PubMed ID: 2117814
[No Abstract] [Full Text] [Related]
13. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology.
Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B
Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370
[No Abstract] [Full Text] [Related]
14. Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection.
Grewal HP; Kotb M; Salem A; el Din AB; Novak K; Martin J; Gaber LW; Gaber AO
Transplant Proc; 1993 Feb; 25(1 Pt 1):132-5. PubMed ID: 7679807
[No Abstract] [Full Text] [Related]
15. Urine sediment cytology in the management of renal allograft recipients.
Madras PN; Simpson MA; Cornaby AJ; Dempsey RA; Clowes GH; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1842-3. PubMed ID: 2652599
[No Abstract] [Full Text] [Related]
16. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M
Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
[TBL] [Abstract][Full Text] [Related]
17. Plasma IL-2 levels and diagnosis of renal transplant rejection.
Johnson CP; Chaharmohal A; Buchmann E; Roza AM; Adams MB
Transplant Proc; 1990 Aug; 22(4):1849-51. PubMed ID: 2389458
[No Abstract] [Full Text] [Related]
18. Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
Cornaby AJ; Simpson MA; Madras PN; Dempsey RA; Clowes GH; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1861-2. PubMed ID: 2652604
[No Abstract] [Full Text] [Related]
19. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules.
Andersen CB; Ladefoged SD; Larsen S
APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171
[TBL] [Abstract][Full Text] [Related]
20. Critical analysis of rejection markers sIL-2R, urinary amylase, and lipase in whole-organ pancreas transplantation with exocrine bladder drainage.
Abendroth D; Capalbo M; Illner WD; Landgraf R; Land W
Transplant Proc; 1992 Jun; 24(3):786-7. PubMed ID: 1376524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
